Documente Academic
Documente Profesional
Documente Cultură
7(3), 1443-1451
Article DOI:10.21474/IJAR01/8779
DOI URL: http://dx.doi.org/10.21474/IJAR01/8779
RESEARCH ARTICLE
Therefore, cervical ripening or preparedness for induction should be assessed before a regimen is selected. Many
methods have been devised to ripen the cervix and this process has been described as preinduction cervical ripening.
Pharmacologic agents available for cervical ripening and labour induction include prostaglandins, misoprostol,
mifepristone and relaxin. Local application of Prostaglandin E 2 (PGE2 or Dinoprostone) has been in use for cervical
ripening since late 1960s. PGE2 administered intravaginally or intracervically, improves Bishop score and induction
to delivery time when compared to those of untreated controls. The local application of PGE 2 results in direct
softening of the cervix by a number of different mechanisms [4,5]. Uterine tachysystole and accompanying fetal
distress is reported following administration of PGE 2 in 1 to 5 percent of women [6].
The use of a cervical catheter also appears to be effective for cervical ripening & has been shown to shorten
induction to delivery interval, decrease caesarean section rate and increase the rate of spontaneous vaginal delivery
[7]. Different catheter balloon volumes ranging from 30 - 80ml and even double balloon catheter have been studied
1444
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
for cervical ripening [8]. The mechanical action of the Foley catheter, strips the fetal membranes from the lower
uterine segment and causes release of lysosomes in the decidual cells, part of which is phospholipase A. These lytic
enzymes act on phospholipase to form arachidonic acid which is converted to prostaglandin, thereby improving the
consistency and effacement of the cervix [9,10]. Failed inductions landing in caesarean section are expected in
closed and firm cervix that is difficult to distend[11]. The advantage of this method over the pharmacological
preparation includes simplicity of preservation, lower cost and reduction of side effects.
This study was planned to compare the efficacy and safety of 30 ml Intracervical Foley catheter balloon with that of
intracervical Dinoprostone gel for cervical ripening for induction of labour at term.
Inclusion Criteria-
1. Pregnant nulliparous women
2. Singleton fetus in cephalic presentation
3. Bishop score <4
4. Intact membranes
5. Patient giving consent
Exclusion Criteria-
1. Any active or purulent infection of lower genital tract
2. Spontaneous labour at start of planned induction
3. Abnormal CTG at start of induction
4. Scarred uterus such as previous caesarean section
5. Malpresentation in labour
6. Cephalopelvic disproportion
7. Severe asthma
8. Tumors occupying the pelvis
9. Major degree placenta previa
10. Carcinoma cervix
11. Active herpes, HIV infection
12. Patient not willing to participate in study
History taking from the patient included the last menstrual period, menstrual cycle regularity, past obstetric and
medical history. Clinical general examination of the patient done. Obstetric examination done. After correlating the
history, clinical findings and previous ultrasound findings, according to the indication, patient selection for induction
is done. After selecting the patients for study, their Bishop score assessed. Major degrees of cephalopelvic
disproportion ruled out.
Method Of Application
Intracervical Foley’s Catheter
Patient was placed in „lithotomy position‟, perineum and vagina cleansed with betadine solution. No.16 foley‟s
catheter was introduced into the endocervix by direct visualization or blindly by locating the cervix with the
examining fingers and guiding the catheter over the hand and fingers through the endocervix and into the potential
space between the amniotic membrane and lower uterine segment. The balloon reservoir was inflated with 30ml of
distilled water. The balloon was strapped to the inner aspect of one thigh with slight tension. Monitering done using
partograph. Bishop score reassessed after six hours and 12 hours. Foley‟s balloon catheter removed after 12 hours if
there is no expulsion. Method considered failure if labour doesn‟t starts after 3 doses. All patients received
prophylactic antibiotics.
1445
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
Successful induction considered if the patient entered the active phase of labour/ bishop score 6.
Discussion:-
The present study entitled “To compare safety and efficacy of intracervical Foley‟s catheter Ballon with
intracervical prostaglandin gel E2 (Dinoprostone) for induction of labour” was a prospective hospital-based study
conducted in nulliparous pregnant women with unfavorable cervix over 37 weeks of gestational age. The main
objective of study was to compare cervical ripening, induction-delivery interval, fetal outcome and mode of delivery
between both methods. 50 patients in each group were recruited and followed till neonatal outcome.
Approximately about 15% labours are induced. The pre-induction cervical ripening is associated with the success of
the induction in women with unfavorable cervix103. Labor induction in an unfavorable cervix is a different and a
lengthy procedure and it is tiring for both the mother and the Obstetrician. The different methods which are used for
cervical ripening are pharmacological methods like oxytocin, estrogens, mifepristone, PGE1, PGE2, etc. and non-
pharmacological (mechanical) methods like Foley‟s catheter, laminaria, amniotomy, etc 103.
When the labour onset occurs physiologically, the cervix ripens before the myometrial contractions start. The
intracervical placement of the Foley catheter induces the cervical ripening without inducing any uterine contractions,
while the prostaglandins affect the cervical ripening and the uterine contractions simultaneously.
In present study, both groups were comparable in age distribution. In both the groups, most of the study subjects
were between the age group of 18-25 years (76% in pgE2 v/s 70% in Foley‟s catheter group). Mean age in PGE2 gel
group was 23.20±3.03 years while Mean age in Intra-Cervical Foley‟s Catheter group was 23.92±3.11 years.
Ziyauddin F et al104 also compared the effectiveness and the safety of the transcervical Foley catheter and the
prostaglandin E2 (PGE2) gel for the induction of labor in 70 women with a previous one caesarean section, in J.N.
Medical College, Aligarh, (U.P), India. Mean age in their study was 25.09 years in Foley‟s catheter group while
26.12 in PGE2 gel group. Similar age distribution was reported by another study from India by Rajeswari A et al 105.
In contrast to our study little higher maternal age was reported by Masood et al 106 who conducted a prospective
quasi-randomised clinical trial which included 90 term pregnant women who were randomly assigned to receive
intracervical foley catheter, dinoprostone 3 mg tablets or misoprostol 25μg tablets vaginally to compare the efficacy,
safety and acceptability for induction of labor in women with previous one caesarean section at term. In this study,
mean age in Intra-Cervical Foley‟s Catheter group was 27.56±4.07 years while in PGE2gel group it was 27.53±3.89
years. It might be due to the fact that they have selected all women with one previous cesarean section.
Similar maternal age was reported by Deshmukh V et al107 who reported mean age in Foley‟s catheter group as
22.27±2.97 years while in Ziyauddin F et al it was 22.00±2.79 years. This study was conducted at GMCH,
Aurangabad from July 2005 to January 2008 to compare the efficacy of intra-cervical Foley‟s catheter with PGE2
gel for pre-induction cervical ripening and it included 200 participants in each group.
In our study, mean gestational age in PGE2 gel group was 39.12±1.33 weeks compared to 39.06±1.18 weeks in
Intra-Cervical Foley‟s Catheter group. Similar to our study, Ziyauddin F et al reported mean gestational age as 39.24
weeks in Foley‟s catheter group and 38.89 weeks in pgE2 gel group. Mean gestational age in study by Masood et al
reported as 39.8±1.03 weeks in Foley‟s catheter and 39.5±0.77 weeks in PGE2 gel group which is also comparable
to our study. Study by Rajeswari A et al also reported similar gestational weeks distribution.
In contrast to our study Ziyauddin F et al reported mean bishop score at start of induction as 2.80 in Foley‟s catheter
group and 2.95 pgE2 gel group. The difference may be due to the fact because in our study we have taken study
subjects with Bishop score ≤4 at start of induction while in study by Ziyauddin F et al, they included study subjects
with Bishop score ≤6 at start of induction so higher values were obtained.
1446
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
Deshmukh V et al reported post-induction mean Bishop score at 6 hours as 7.04±1.72 in Foley‟s Catheter group v/s
7.08±1.87 in pgE2 gel group. Author reported no significant difference between both group at post induction.
Post-induction mean Bishop score at 12 hours in our study was 6.0 in PGE2 gel group while it was 7.58±3.11 in
Intra-Cervical Foley‟s Catheter group but at 12 hours this difference was statistically non-significant. Similar to our
study, Ziyauddin F et al reported mean bishop score at post induction at 12 hours as 7.45 in Foley‟s catheter group
and 6.95 in pgE2 gel group.
Similar findings were reported by Fareed P et al who compared the efficacy of intracervical Foleys catheter and
intracervical PGE2 gel in preinduction cervical ripening in Srinagar from Mar 2011- Mar 2013 in 200 patients. In
this study improvement in the bishop‟s score in Group A was 5.3+1.1) and in Group B it was 5.1+1.1; however no
significant difference in the mean changes was observed.
In the study done by Marta Jozwiak et al, they found that induction to delivery duration in PGE2 group was
significantly less as compared to Foleys group, P value was 0.0001. But in the study done by Azra Naseem et al they
found that the induction to delivery duration was significantly less in Foleys group as compared to PGE2 group with
P value 0.008.
Maternal complications:
In our study, common maternal complication observed were Intrapartum pyrexia (1 case in pgE2 gel group and 8
cases in Foley‟s catheter group) and puerperal pyrexia (1 case in pgE2 gel group and 4 cases in Foley‟s catheter
group). 1 case of hyperstimulation was also seen in pgE2 gel group. Apart from that we have not seen any other
1447
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
complication in mothers. Ziyauddin F et al also reported also reported 1 case of uterine hypertonicity and 1 case of
puerperal pyrexia in pgE2 gel group while 2 cases of puerperal pyrexia were seen in Foley‟s group but in contrary to
our study, 13 cases of PPH were also reported by author (5 in Foley‟s group and 8 in pgE2 gel group). Rajeswari A
et al did not found any case of infection but side effects associated with pgE2 gel like uterine hypertonicity and
tachysystole were reported in 4 & 2 cases respectively.
Fetal outcome:
Fetal outcome data showed no significant difference between Foley‟s catheter Group and pgE2 gel Group with
respect to NICU admission rate (6 and 6 respectively). Thus, the present study shows that the fetal outcome results
were also comparable in both the groups. Compare to our study, NICU admission rate was very high in study by
Deshmukh V et al (18.5% in Foley‟s group v/s 20.5% in pgE2 gel group) but no significant difference was reported.
Similar to present study, Rajeswari A et al also reported lesser NICU admission rate (12% in Foley‟s group v/s 5% in
pgE2 gel group) and both groups were found to be comparable. 5 Cases in Foley‟s group and 4 cases in pgE2 gel
group were admitted to NICU in study by Masood A et al.
In our study, PGE2 gel produced better effects compare to Foley‟s catheter in the ripening of the cervix in women at
6 hrs but both were comparable at 12 hrs. The main advantage of the PGE2 gel is that early ripening of cervix, lesser
caesarean rate and infection rate as compared to the Foley‟s catheter while disadvantage is higher chances of uterine
hypertonicity or tachysystole.
Ravasia DJ et al conducted a study on the VBAC induction and showed that the Foley catheter induction was
associated with a lowest rupture rate in the induced TOL group and that it was comparable to the results in the
spontaneous TOL group. The PGE2 exposure during the TOL was associated with more than a 6fold increase in the
uterine ruptures as compared to that in the spontaneous labour.
In the large NICHD study, the use of the prostaglandin-based medications to induce labour was associated with a
nonsignificant increase in the risk of the uterine rupture as compared to the mechanical methods of induction of
labour (such as the use of a Foley catheter). In this study, the risk of the uterine rupture was 140/10,000 inductions
with the use of prostaglandins as compared to the 89/10,000 inductions with the use of a Foley catheter to dilate the
cervix.
According to an open label randomized control trial which was done by the PROBAAT study group, in women with
unfavorable cervices at term, the induction of labour with a Foley catheter was similar to the induction of labor with
the Prostaglandin E2 gel, with fewer maternal and neonatal side effects.
Result:-
CHARACTERSTIC Intracervical PGE2 gel Intracervical Foley catheter group P value
group
1. Mean age 23.20±3.03 23.92±3.11 0.49
2. Cases G1 84% G1 86% 0.73
according
gravida G2 12% G2 8%
G3 4% G3 6%
40-40wk+6d 26.0%
40-40wk+6d 30%
41-41wk+6d 14.0%
41-41wk+6d 11%
1448
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
42wks 2.0%
42wks 1%
0 14% 0.95
0 12%
1 40%
1 42%
2 20%
2 24%
3 22%
3 20%
4 4%
4 2%
4. Bishop
score at 0
hour
5. Bishop ≤5 26.0% <0.01
score at 6
hours 6-10 72.0%
>10 2.0%
1449
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
Quantitative data was expressed in mean, standard deviation and difference between two comparable groups were
tested by student „t‟ test or Mann Whitney „U‟ test while qualitative data were expressed in percentage. Difference
between the proportions were tested by chi square test. „P‟ value less than 0.05 was considered statistically
significant.
Result:-
In present study, both groups were comparable in age distribution. In both the groups, most of the study subjects
were between the age group of 18-25 years (76% in pgE2 v/s 70% in Foley‟s catheter group). Mean age in PGE2 gel
group was 23.20±3.03 years while Mean age in Intra-Cervical Foley‟s Catheter group was 23.92±3.11 years. Mean
gestational age in PGE2 gel group was 39.12±1.33 weeks compared to 39.06±1.18 weeks in Intra-Cervical Foley‟s
Catheter group. At start of induction mean Bishop score was 1.62±1.10 in PGE2 gel group while it was 1.58±1.01 in
Intra-Cervical Foley‟s Catheter group. Deshmukh V et al also reported similar pre-induction mean Bishop score
(1.48±0.67 in Foley‟s Catheter group v/s 1.59±0.59 in pgE2 gel group). In our study, post-induction mean Bishop
score at 6 hours was 6.56±2.13 in PGE2 gel group while it was 4.70±2.21 in Intra-Cervical Foley‟s Catheter group.
1450
ISSN: 2320-5407 Int. J. Adv. Res. 7(3), 1443-1451
Mean change in Bishop score between 0 to 6 hours was significantly higher in pgE2 gel group (4.94±1.78) compare
to Foley‟s catheter group (3.12±1.78). The rate of LSCS in pgE2 gel group was 10% and 32% in Foley‟s catheter
group respectively. The induction delivery interval showed significantly higher time in intracervical Foley‟s catheter
groups. The mean induction delivery internal was 13.80±3.83 hrs in Foley‟s group and 9.65±2.13 hrs in PGE2
group. In our study, common maternal complication observed were Intrapartum pyrexia (1 case in pgE2 gel group
and 8 cases in Foley‟s catheter group) and puerperal pyrexia (1 case in pgE2 gel group and 4 cases in Foley‟s
catheter group). 1 case of hyperstimulation was also seen in pgE2 gel group. Apart from that we have not seen any
other complication in mothers. The present study shows that the fetal outcome results were also comparable in both
the groups.
Now, there is recent trend of reintroducing the mechanical methods like the Foley catheter, as there is an availability
of sterile devices, controlling one of the principal contraindications- infection. Such mechanical methods are
advantageous in terms of their reversibility and the reduced expenditure. But Foley‟s catheter has been linked with a
possibility of infections in some larger studies. Thus, tremendous attention should be drawn towards carrying out
aseptic measures while it is being inserted, to avoid maternal and probable neonatal infections.
Refrences:-
1. B. A. Brindley and R. J. Sokol, “Induction and Augmentation of Labor. Basis and Methods for Current
Practice,” Obstetrical & Gynecological Survey, Vol. 43, No. 12, 1988, pp. 730-743. doi:10.1097/00006254-
198812000-00004 [Citation Time(s):1]
2. K. F. Trofatter, “Cervical Ripening,” Clinical Obstetrics abd Gynecology, Vol. 35, No. 3, 1992, pp. 476-
486. doi:10.1097/00003081-199209000-00007 [Citation Time(s):1]
3. J. E. Stempel, R. P. Prins and S. Dean, “Preinduction Cervical Ripening: A Randomized Prospective
Comparison of the Efficacy and Safety of Intravaginal and Intracervical Prostaglandin E2 Gel,” American
Journal of Obstetrics & Gynecology, Vol. 176, No. 6, 1997, pp. 1305-1312. doi:10.1016/S0002-
9378(97)70350-8 [Citation Time(s):1]
4. N. Uldbjerg, G. Ekman and A. Malmstrom, “Ripening of the Human Uterine Cervix Related to Changes in
Glycosaminoglycans and Collagenolytic Activity,” American Journal of Obstetrics & Gynecology, Vol. 147,
No. 6, 1983, pp. 662-666.
5. K. F. Trofatter, D. Bowers, R. N. Standby, A. Gall and A. P. Killam, “Preinduction Cervical Ripening with
Prostaglandin E2 Gel,” American Journal of Obstetrics & Gynecology, Vol. 153, No. 3, 1985, pp. 268-271.
6. R. P. Prins, R. N. Bolton and C. Mark, “Cervical Ripening with Intravaginal Prostaglandin E2Gel,” Obstetrics &
Gynecology, Vol. 63, 1984, pp. 697-702. [Citation Time(s):1]
7. C. James, A. Peedicayil and L. Seshardi, “Use of the Foley Catheter as a Cervical Ripening Agent Prior to
Induction of Labor,” International Journal of Gynecology & Obstetrics, Vol. 47, No. 3, 1994, pp. 229-
232. doi:10.1016/0020-7292(94)90566-5 [Citation Time(s):1]
8. D. A. Guinn, A. R. Goepfert, M. Christine, J. Owen and J. C. Hauth, “Extra-Amniotic Saline, Infusion and
Intracervical Dinoprostone Gel for Cervical Ripening,” Obstetrics & Gynecology, Vol. 182, 2000, pp. 1039-
1044. [Citation Time(s):1]
9. D. J. Sherman, E. Frenkel, J. Tovbin, S. Arieli, E. Caspi and I. Bukovsky, “Ripening of the Unfavorable Cervix
with Extra-Amniotic Catheter Balloon: Clinical Experience and Review,” Obstetrical & Gynecological Survey,
Vol. 51, No. 10, 1996, pp. 621-627. doi:10.1097/00006254-199610000-00022
10. F. Arias, “Pharmacology of Oxytocin and Prostaglandins,” Clinical Obstetrics and Gynecology, Vol. 43, No. 3,
2000, pp. 455-468. doi:10.1097/00003081-200009000-00006.
1451